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density, end myocyto width was measured with 400x on 1 Hm slides by light 
microscopy, Intorstlttnnl tissue w(]s expressed as % of total area, 
Results: The stonosis reduced moan LAD flow from 0,90 ± 0.12 to 0,55 
~: 0.12 ml/min/g nnd wall thickening from 38 :~- 3% to 10 "J: 6%. Alter 4 weeks 
of repeduston, wnnll thickening in HM reoovered to 28 ± 4%, Results el the 
mlcrosooplo study am presented In the t81ble: 
Conlrol Day 7 of 6tenonl~ Roporfu~lon 
Myocyta Den,lty 57 ;t 1 45 ~; 4' ~14 ± 3 
Myocyl~ wldlh (urn) 17,7 ~ 0,3 2P..2 :t~ P.,0' 182 ~ (],0 
Intcr~llti~l¢ontl~nt (%) 1~,0 ~: 0,2 17,8 ~ 2,3' t6,t .t, 1,4' 
'P ,~ 0,01 Compared to b~aol~ne 
Concluf~lon~: Reped(]slon of hlbern81ting my(]oardigm for 4 weeks restores 
myecyte number n(]mss th(] LV we111, Indlc81tlng recov(]ry in the armngomect 
ot myo(~yto bgndlee~ 81nd pmllal regression of rnyuwte hypedrophy, 
~ Increased Level t  and Thrombln  Cytok lne 
Generat ion In 8table Angina are Radu©e¢l by 
Aspir in,  A Randemlud ,Cont ro l led ,  Cro#l ,ovet  
'rdal 
I, Ikonomidls, F, Andmottl ~ , C, St8110nsdla, C, Pit,ayes, E, Eoonomou, 
P, "l'ogtogz818, E Nihoyannapo(]l(]s ~ , Ca~tology Ippocr~fian Hopif~l, Ath(]ns, 
GroPe: fH81mmot~mlfh Ho,~pifal Lonclon, UK 
~ckm¢~nd: Ro~enlty, the redu~tio, o! th(] ask tar myooardi811 Intamtion by as- 
pirin (ASA) h~s b(](]n attrlbuteed to its 81ntilnll~mm81tory p op(idle81 even when 
admlntst(]red P.f low doses. M~cmplt819(] colony 811tmu181ting factor (MCSF) 
causes m81crOphBg(]/monocyto acttv81tlon 81nd thus, release of vasoaotlve 
e(]bM81n~ms, intedeuklns lb (ILlb) and 6 ilL0) end tissue factor. Our aim was 
to tnvestlgst(] whether high cytoktne levi]Is 81nd Incm81sed thrombln goner. 
allen a) occur In stable angina (SA) b) are re181ted to transient myocardial 
tschaemla and c) 81m reduced by aspirin 
M~thocls: We measured prothrombln fragments (PF1 + 2, nmole/I) MCSF, 
ILl b, tL8 (pg/ml) plosmrt levels in 60 patients with SA and in 2 t he811thy centers 
by ELIS~, S81mplas were obtained at the 81nd o! a 46 h Halter monitoring (HM), 
All patients had anglogmphlcalty documented dlso81se and positive exemtso 
test. Fourty patients h81d isch81emla in HM and were randomly treated with 
ASA 300 rag, o.d, or placebo for 3 weeks in a double blind, erase-over trial. 
Melee(Is: PF1 + 2, MCSF, and IL6 were Increased in patients with SA 
comp81md to controls (table, p < 0,01), Analysis el variance showed that 
MCSF end ILlb increased according 1o the number of diseased (1-2-3) 
vessels (p - 0.05), Only MCSF was higher in patients with lschaemia in HM 
than those without (1124 ~ 651 vs 528 ~ 417, p -: 0.01). Although, PF1 + 2 
and cytokine levels wore decreasod by ASA (181bte, p - 0.05), they remained 
higher than those in controls (p ~ 0,05) 
~A ASA CONTROLS p 
PF1 * 2 226 t t 8 1 73 't 1 2 0.93 .t 0,5 -0.01 
MCSF 1076 t ~,13 950 t .567 479 t 207 .0.05 
IL0 4.2 ~: 1 3 3.5 "t 081 2.0 :t 0,9 • 0.05 
Conclusion: Elevated cytokine and PF1 + 2 plasma levels in SA sug- 
gest the presence of enhanced inflammatory activity and incre81sed threm- 
bin generation. Only MCSF was related to both extent of disease and 
daily life ischaemia. Reduction of the above factors by ASA may repre- 
sent an additional mechanism of its therapeutic action in coronanj artery 
disease. 
I 1004-136J  Estrogen and Progesterone Decrease Lipid 
Loading In Human Female Macrophages  
Jane A. McCrohen, Wondy Jessup, Shirley Nakhla, David S. Celermajer. 
The Heart Research Institute, Sydney, Australia 
Bac.=(grounc/: BaSed on the lower incidence of athereselerosis in females, we 
hypothesized that estrogen and progesterone may reduce lipid-loading in 
human macrophages (ie. foam cell formation). 
Methods: Monocytes from healthy female donors (n = 5) were plated out 
in phenol-red free RPMI and allowed to differentiate into macrophagos over 
10 days. Cells were treated from days 2-10 with either control media, 17 
-estradid (2 nM and 200 nM) ~ the estrogen receptor antagonist ICI 182 
780, diothylstilbestrol (DES, non-stereidal estrogen), 17~-estradiol (17.¢.E, 
inactive stereoisomer) or progesterone 10 nM. Lipid-loading was assessed 
by HPLC after a 48 hr incubation (days 8-10) with acetylated LDL in lipopro. 
tein-deficient human serum. Triplicate wells were used for each condition, in 
each experiment. 
Results: Macrophages treated with 17/~.estradiol showed a significant 
dose-related reduction in cholesterol ester formation vs controls (88 ± 12% 
and 78 ± 14% for 2nM end 200aM ostradiol respectively vs 100 ± 5%. 
p = 0.04 by ANOVA). Them was a similar trend in the levels of free and 
total cholesterol (p : 0,06). These effects worn not blocked by ICI 182 780, 
Progesterone alone (10 nM) was also associated with a marked redu(]tion in 
choloeter01 ester loading (16 ± 5%, p .~ 0,00 ;). In ooantrast, DES end 17..E 
did not reduce lipid loading, E81trogen exposure In male mecmphegea (n = 
4), showed no algnlfloant effect (89 :E 13%). 
Conclusion: 17p-estradlo181nd progesterone reduce lipid loading in human 
f(]m8110 mecrophegoa, consistent with en etheropretective effect, 
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The pnman/deferminant el 181re Outcome following corona w stealing m the 
rain, slant die+ (MSD) or rain. stant area (MSA) achieved. Slant expansion 
continues to increase as press(ire is raised from 12 to 18 arm. To study 
whether luminal dimensions can be safely further increased by using over. 
sized t)alloorls at high pressure, Patroaz-Schatz steals were implanted at 18 
arm. in 143 COnSecutive Isns in 120 pts at 7 centers. IVUS was pedonned. 
and it ~0.7 mrs of vessel remodeling was present at the lesion (external 
elastic membrane die. • ref. segment lumen die. ~:0.7 mm). the st0nt was 
further expanded with a balloon ._-0.5 mm larger at 16 atm. To minimize 
edge dissections found in prior trials of aggressive stealing, a novel focally 
expanding balloon was used which grows 0.5 mm larger centrally (within 
the slant) than outside the stent (the CVD FACT'=). QCA and IVUS were 
performed pro. pest standard stenting, and post focal stenting, and analyzed 
at independent core labs (Stanford). 
Results: By QCA, the baseline mean tel. dia. was 3.02 ± 0.48 mm and 
MLD was 1.10 ± 0.53 mm Remodeling was present to permit focal stent 
"overexpanston" in 120 of 143 lens (84%). 
slandaz'd slanting local slanting p value 
Mezzo balloon dta 336 ~ 037 3 87 ~ O 37 - O 0001 
Bai)oon-afto~ r~tlo 112 ~: (]17 1.33 -~ 020 - OOOOt 
MSD (turn). QCA 2.78 J: 0.43 2.93 x 0.44 -.0 0001 
MSO (rnm). IVUS 2.77 i Q39 2(]5 ~ 0.38 .00001 
MSA (rnm ~') - IVUS 7.29 ± 1 89 8.22 t 1 90 .00001 
By QCA, dissections were present at 4 stent edges after standard balloons 
and 1 slant edge alter focal upsizing, No pedorations, subacute thromboses 
or major ischomic complications occun'ed. 
Conclusions: Balloons traditionally considered ovemized, applied focally 
within the slant borders, may safely be used in the majority of lesions, and 
result in improved luminal dimensions. 
• I s  High Pressure Inflation Necessary for Optimal 
Stent ing? 
S. Elezi, A. Kastrati. J. Pache. J. Dirschinger, A. Sch~mig. 1. MedJzinische 
Klinik & Deutsches Herzzentrum, TU Munchen, Germany 
High pressure inflation after comnan/stent placement has been employed 
to achieve optimal stent deployment. However, it is not clear whether this 
is due to more radial tome generated by high pressure inflation o= simply 
by bigger balloon size. Quantitative angiograph¢c analysis we performed 
on 2724 lesions (2096 patients). The adequacy of stent deployment was 
based on pe, :eat diameter .~tenosis (DS) immediately after stent placement. 
Balloon to vessel ratio (BRD) and balloon pressure (BP) correlated with DS, 
but there was a much stronger correlation for BRD (r = -0.63 vs. r = -0.21, 
p < 0.001). When both BRD and BP were entered in a multivariate stepwise 
linear regression analysis (DS as a outcome variable), together with other 
factors, a significant independent role could be documented only for BRD (/~ 
= -0.641, p < 0.001). 
